Figure 3.
(A) Schematic illustrations for the construction of chitosan/alginate-stabilized perfluorohexane (PFH) nanodroplets and the ultrasound-responsive and pH-responsive drug release. Reproduced with permission from [92], Int J Biol Macromol, 2021. (B) Schematic illustration of theranostic nanoprobes showing tunable size and performance in vivo derived from multi-stimulation sensitivity. Reprinted from Journal of Controlled Release. Reproduced with permission from [93], ACS Nano, 2018.
